Skip to search formSkip to main contentSkip to account menu

SCH 412348

Known as: SCH-412348, SCH412348 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats
2013
2013
MitoPark mice, an animal model of Parkinson’s disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A2A antagonist SCH 412348
Psychoses are debilitating side effects associated with current dopaminergic treatments for Parkinson's disease (PD). Prepulse… 
2010
2010
Evaluation of the Selective A2A Receptor Antagonist, SCH 412348, and the D2/D3 Receptor Agonist Pramipexole in Rat Models of Psychotic and Obsessive Behavior
Dopamine D2/D3 receptor agonists, used to treat Parkinson's Disease (PD), have serious side effects, including hallucinations and… 
2009
2009
Characterization of the Potent and Highly Selective A 2 A Receptor Antagonists Preladenant and SCH 412348 in Rodent Models of Movement Disorders and Depression
Department of Neurobiology, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. (RAH, GBV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)